{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:20:01Z","timestamp":1781648401381,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This article explores both reported and personal experiences of intersectionality within the healthcare system, which is often due to systemic inequalities as well as deep ingrained perceptions and opinions. With my perspective as both a medical student and rare disease patient battling generalised Myasthenia Gravis, I uncover and expose the aspects of intersectionality which are often brushed under the carpet. Moreover, I identify potential routes which we may collectively, as both clinicians and patients, embark upon to navigate our way out of this systemic snare. For those reading and engaging with this article, I endeavour to humanise the publicised figures surrounding rare disease and emphasise that within each figure there are patients, just like myself, who too may be experiencing the multifactorial issues arising from intersectionality. Furthermore, the coronavirus pandemic has highlighted and emphasised the pre-existing divide in the treatment of societal groups, for those both receiving and delivering care. We have long attempted to plaster over this chronic wound however the distressing outcomes of this pandemic have forced us to address this shameful truth from its core. Intersectionality is a disease which is destroying our healthcare system from within. However, unlike many rare diseases, intersectionality can be abolished.<\/jats:p>","DOI":"10.1186\/s13023-022-02255-3","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T01:02:30Z","timestamp":1646010150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exploring intersectionality: an international yet individual issue"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5258-1295","authenticated-orcid":false,"given":"Zainab","family":"Alani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"2255_CR1","unstructured":"Epi cell, Surveillance cell and Health Intelligence team; Public Health England. Disparities in the risk and outcomes of COVID-19. 2021. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/908434\/Disparities_in_the_risk_and_outcomes_of_COVID_August_2020_update.pdf. Accessed 16 Oct 2021."},{"key":"2255_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e8497","volume":"345","author":"J Spillane","year":"2012","unstructured":"Spillane J, Higham E, Kullmann DM. Myasthenia gravis. BMJ. 2012;345: e8497. https:\/\/doi.org\/10.1136\/bmj.e8497.","journal-title":"BMJ"},{"key":"2255_CR3","unstructured":"Elahi AS. Coronavirus: BAME doctors feel 'let down' over risk checks. 2020. https:\/\/www.bbc.co.uk\/news\/health-53021628. Accessed 16 Oct 2021."},{"issue":"10","key":"2255_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040638","volume":"10","author":"M Perkin","year":"2020","unstructured":"Perkin M, Heap S, Crerar-Gilbert A, et al. Deaths in people from Black, Asian and minority ethnic communities from both COVID-19 and non-COVID causes in the first weeks of the pandemic in London: a hospital case note review. BMJ Open. 2020;10(10): e040638. https:\/\/doi.org\/10.1136\/bmjopen-2020-040638.","journal-title":"BMJ Open"},{"key":"2255_CR5","unstructured":"Public Health Scotland. What are health inequalities? 2021. http:\/\/www.healthscotland.scot\/health-inequalities\/what-are-health-inequalities. Accessed 17 Oct 2021."},{"issue":"1","key":"2255_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-8124-z","volume":"20","author":"JG Rivenbark","year":"2020","unstructured":"Rivenbark JG, Ichou M. Discrimination in healthcare as a barrier to care: experiences of socially disadvantaged populations in France from a nationally representative survey. BMC Public Health. 2020;20(1):1\u201310. https:\/\/doi.org\/10.1186\/s12889-019-8124-z.","journal-title":"BMC Public Health"},{"key":"2255_CR7","unstructured":"Oxford English Dictionary. Intersectionality. 2015.\u00a0https:\/\/www.oed.com\/view\/Entry\/429843?redirectedFrom=intersectionality&. Accessed 10 Oct 2021."},{"key":"2255_CR8","unstructured":"Raleigh V, Holmes J; The King's Fund. The health of people from ethnic minority groups in England. 2021. https:\/\/www.kingsfund.org.uk\/publications\/health-people-ethnic-minority-groups-england. Accessed 10 Oct 2021."},{"key":"2255_CR9","unstructured":"BMA. Sewell report ignores \u2018well-documented\u2019 evidence of structural racism in the NHS, says BMA. 2021. https:\/\/www.bma.org.uk\/bma-media-centre\/sewell-report-ignores-well-documented-evidence-of-structural-racism-in-the-nhs-says-bma. Accessed 17 Oct 2021."},{"issue":"1","key":"2255_CR10","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.amepre.2016.09.024","volume":"52","author":"I Stepanikova","year":"2017","unstructured":"Stepanikova I, Oates G. Perceived discrimination and privilege in health care: the role of socioeconomic status and race. Am J Prev Med. 2017;52(1):S86\u201394. https:\/\/doi.org\/10.1016\/j.amepre.2016.09.024.","journal-title":"Am J Prev Med"},{"key":"2255_CR11","unstructured":"National Institute of Neurological Disorders and Stroke. Myasthenia gravis fact sheet. 2020. https:\/\/www.ninds.nih.gov\/Disorders\/Patient-Caregiver-Education\/Fact-Sheets\/Myasthenia-Gravis-Fact-Sheet. Accessed 8 Feb 2022."},{"key":"2255_CR12","unstructured":"World Health Organization. Priority medicines for Europe and the World \u201ca public health approach to innovation\u201d. Background Paper 6.19 Rare Diseases. 2013. https:\/\/www.who.int\/medicines\/areas\/priority_medicines\/BP6_19Rare.pdf. Accessed 8 Feb 2022."},{"key":"2255_CR13","unstructured":"Doghramji PP. Screening and laboratory diagnosis of autoimmune diseases using antinuclear antibody immunofluorescence assay and specific autoantibody testing. 2016. https:\/\/www.aafp.org\/dam\/AAFP\/documents\/about_us\/sponsored_resources\/Quest_%20ANA-IFA_Monograph.pdf. Accessed 9 Feb 2022."},{"key":"2255_CR14","unstructured":"Benaroya Research Institute. Diagnosing autoimmune diseases. 2017. https:\/\/www.benaroyaresearch.org\/blog\/post\/diagnosing-autoimmune-diseases#:~:text=Being%20diagnosed%20with%20an%20autoimmune%20disease%2C%20such%20as,period%20the%20patient%20typically%20has%20seen%20four%20doctors. Accessed 9 Feb 2022."},{"key":"2255_CR15","unstructured":"Rare Disease UK. Illuminating the rare reality. 2019. https:\/\/www.raredisease.org.uk\/wp-content\/uploads\/sites\/7\/2019\/02\/Illuminating-the-rare-reality-2019.pdf. Accessed 9 Feb 2022."},{"key":"2255_CR16","unstructured":"Genetic Alliance UK. Rare diseases. 2016. https:\/\/geneticalliance.org.uk\/information\/learn-about-genetics\/chromosomal-disorders-2\/. Accessed 8 Feb 2022."},{"key":"2255_CR17","first-page":"18","volume-title":"Understanding health inequalities in Aotearoa","author":"J Forman","year":"2008","unstructured":"Forman J. Health inequalities and need associated with rare diseases. In: Dew K, Matheson A, editors. Understanding health inequalities in Aotearoa. Dunedin: Otago University Press; 2008. p. 18\u201318."},{"issue":"3","key":"2255_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11211-019-00332-w","volume":"32","author":"S Ra\u00efs Ali","year":"2019","unstructured":"Ra\u00efs Ali S, Tubeuf S. (In)-equality in the allocation of R&D resources for rare diseases. Soc Justice Res. 2019;32(3):277\u2013317. https:\/\/doi.org\/10.1007\/s11211-019-00332-w.","journal-title":"Soc Justice Res"},{"key":"2255_CR19","unstructured":"UK Health Departments. Equality analysis: UK plan for rare diseases. 2012. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/215142\/dh_132882.pdf. Accessed 8 Feb 2022."},{"issue":"3","key":"2255_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/pbc.24361","volume":"60","author":"SC Nelson","year":"2012","unstructured":"Nelson SC, Hackman HW. Race matters: perceptions of race and racism in a sickle cell center. Paediatr Blood Cancer. 2012;60(3):451\u20134. https:\/\/doi.org\/10.1002\/pbc.24361.","journal-title":"Paediatr Blood Cancer"},{"key":"2255_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-90-481-9485-8_14","volume-title":"Rare diseases epidemiology","author":"A Kole","year":"2010","unstructured":"Kole A, Faurisson F. Rare diseases social epidemiology: analysis of inequalities. In: Posada de la Paz M, Groft S, editors. Rare diseases epidemiology. Dordrecht: Springer; 2010. p. 223\u201350. https:\/\/doi.org\/10.1007\/978-90-481-9485-8_14."},{"key":"2255_CR22","unstructured":"Eurordis Rare Diseases Europe. Rare disease patients\u2019 opinion on the future of rare diseases. 2021. https:\/\/download2.eurordis.org\/rbv\/rare2030survey\/reports\/RARE2030_survey_public_report_en.pdf. Accessed 8 Feb 2022."},{"key":"2255_CR23","unstructured":"European Union. EU research on rare diseases. 2020. https:\/\/ec.europa.eu\/info\/research-and-innovation\/research-area\/health-research-and-innovation\/rare-diseases_en. Accessed 11 Feb 2022."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02255-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02255-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02255-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T01:02:50Z","timestamp":1646010170000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02255-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2255"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02255-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"2 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"I consent for my manuscript to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}